Treatment Response Evaluation of Cardiac Amyloidosis Using Serial T1- and T2-Mapping Cardiovascular Magnetic Resonance Imaging

다국어 초록 (Multilingual Abstract)

Amyloidosis is a multisystemic disease characterized by the accumulation of abnormal proteins in extracellular spaces in various organs, with frequent involvement of the myocardium.
We report a case of a patient who had cardiac amyloidosis with a trend of reduction in native T1 and T2 values and extracellular volume fraction on serial cardiac magnetic resonance imaging after chemotherapy and stem cell transplantation. The native T1 value and the extracellular volume fraction are closely associated with tissue amyloid burden in amyloidosis patients. This case demonstrated that cardiac magnetic resonance imaging may be used as a non-invasive and quantitative biomarker in the treatment monitoring of amyloidosis.

참고문헌 (Reference)

1 Dubrey SW, "The clinical features of immunoglobulin light-chain(AL)amyloidosis with heart involvement" 91 : 141-157, 1998

2 Robbers LF, "T1 mapping shows increased extracellular matrix size in the myocardium due to amyloid depositions" 5 : 423-426, 2012

3 Banypersad SM, "T1 mapping and survival in systemic light-chain amyloidosis" 36 : 244-251, 2015

4 Dispenzieri A, "Serum cardiac troponins and Nterminal pro-brain natriuretic peptide : a staging system for primary systemic amyloidosis" 22 : 3751-3757, 2004

5 Hur DJ, "Serial native T1 mapping to monitor cardiac response to treatment in light-chain amyloidosis" 9 : e004770-, 2016

6 Kumar S, "Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements" 30 : 989-995, 2012

7 Karamitsos TD, "Noncontrast T1 mapping for the diagnosis of cardiac amyloidosis" 6 : 488-497, 2013

8 Ridouani F, "Myocardial native T2 measurement to differentiate light-chain and transthyretin cardiac amyloidosis and assess prognosis" 20 : 58-, 2018

9 Aus dem Siepen F, "Extracellular remodeling in patients with wild-type amyloidosis consuming epigallocatechin-3-gallate : preliminary results of T1 mapping by cardiac magnetic resonance imaging in a small single center study" 104 : 640-647, 2015

10 Kristen AV, "Cardiac amyloid load : a prognostic and predictive biomarker in patients with light-chain amyloidosis" 68 : 13-24, 2016